"A new vision for keratoconus: Epioxa redefines treatment after a decade-long wait" was originally created and published by ...
“Keratoconus appears positively associated with multiple immune-mediated diseases, which provides a population-based argument that systemic inflammatory responses may influence its onset,” Janneau L.
The Eye Care Network sat down with Rajesh K. Rajpal, MD, ophthalmologist and founder of See Clearly Vision Group in McLean, ...
Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for ...
Glaukos’ Epioxa allows cross-linking therapy for keratoconus without requiring an incision. The biotech expects to launch the ...
It is often taught that keratoconus is commonly associated with Ehlers-Danlos syndrome, or EDS, but there is surprisingly little direct literature collaborating this connection. In fact, there are ...
The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare ...
SAN FRANCISCO (KGO) -- Stephen Curry's revelation that he as dealing with the degenerative eye disease, Keratoconus, shocked basketball fans. The disease, which causes the cornea to thin and change ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...
MENLO PARK, Calif.--(BUSINESS WIRE)--Avellino Lab USA, Inc. (Avellino), in honor of World Keratoconus Day, today announced a $25,000 donation to the National Keratoconus Foundation (NKCF) to support ...
Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Ladies and gentlemen, thank you for standing by. My name is Colby, and I’ll be your conference operator today. At this time, I would like to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback